<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">23108260</PMID>
      <DateCompleted>
        <Year>2013</Year>
        <Month>05</Month>
        <Day>07</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>10</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1470-7330</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>12</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2012</Year>
              <Month>Oct</Month>
              <Day>26</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cancer imaging : the official publication of the International Cancer Imaging Society</Title>
          <ISOAbbreviation>Cancer Imaging</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A-Z of malignant peripheral nerve sheath tumors.</ArticleTitle>
        <Pagination>
          <StartPage>475</StartPage>
          <EndPage>483</EndPage>
          <MedlinePgn>475-83</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1102/1470-7330.2012.0043</ELocationID>
        <Abstract>
          <AbstractText>This article reviews the typical and atypical locations, imaging findings, local recurrence, and metastatic pattern of malignant peripheral nerve sheath tumors (MPNSTs). MPNSTs are rare soft tissue sarcomas, commonly occur in extremities, and are often associated with neurofibromatosis. Distinction between benign and malignant tumors can be challenging on imaging. MPNSTs have a poor prognosis; however, rhabdomyoblastic differentiation (malignant triton tumor), which has imaging features similar to MPNSTs, is associated with even more aggressive behavior.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kamran</LastName>
            <ForeName>S C</ForeName>
            <Initials>SC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Imaging, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02115, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shinagare</LastName>
            <ForeName>A B</ForeName>
            <Initials>AB</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Howard</LastName>
            <ForeName>S A</ForeName>
            <Initials>SA</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hornick</LastName>
            <ForeName>J L</ForeName>
            <Initials>JL</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ramaiya</LastName>
            <ForeName>N H</ForeName>
            <Initials>NH</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2012</Year>
          <Month>10</Month>
          <Day>26</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Cancer Imaging</MedlineTA>
        <NlmUniqueID>101172931</NlmUniqueID>
        <ISSNLinking>1470-7330</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018317" MajorTopicYN="N">Nerve Sheath Neoplasms</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D049268" MajorTopicYN="N">Positron-Emission Tomography</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012509" MajorTopicYN="N">Sarcoma</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2012</Year>
          <Month>10</Month>
          <Day>31</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2012</Year>
          <Month>10</Month>
          <Day>31</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2013</Year>
          <Month>5</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">23108260</ArticleId>
        <ArticleId IdType="pmc">PMC3483600</ArticleId>
        <ArticleId IdType="doi">10.1102/1470-7330.2012.0043</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Stucky CC, Johnson KN, Gray RJ, et al.  Malignant peripheral nerve sheath tumors (MPNST): the Mayo Clinic experience. Ann Surg Oncol. 2012;19:878–885. doi: 10.1245/s10434-011-1978-7. . PMid:21861229.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1245/s10434-011-1978-7</ArticleId>
            <ArticleId IdType="pubmed">21861229</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ramanathan RC, Thomas JM. Malignant peripheral nerve sheath tumors associated with von Recklinghausen’s neurofibromatosis. Eur J Surg Oncol. 1999;25:190–193. doi: 10.1053/ejso.1998.0625. . PMid:10218464.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/ejso.1998.0625</ArticleId>
            <ArticleId IdType="pubmed">10218464</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li CS, Huang GS, Wu HD, et al.  Differentiation of soft tissue benign and malignant peripheral nerve sheath tumors with magnetic resonance imaging. Clin Imaging. 2008;32:121–127. doi: 10.1016/j.clinimag.2007.05.006. . PMid:18313576.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.clinimag.2007.05.006</ArticleId>
            <ArticleId IdType="pubmed">18313576</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anghileri M, Miceli R, Fiore M, et al.  Malignant peripheral nerve sheath tumors: prognostic factors and survival in a series of patients treated at a single institution. Cancer. 2006;107:1065–1074. doi: 10.1002/cncr.22098. . PMid:16881077.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cncr.22098</ArticleId>
            <ArticleId IdType="pubmed">16881077</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Levy AD, Patel N, Dow N, Abbott RM, Miettinen M, Sobin LH. From the archives of the AFIP: abdominal neoplasms in patients with neurofibromatosis 1: radiologic-pathologic correlation. Radiographics. 2005;25:455–480. doi: 10.1148/rg.252045176. . PMid:15798063.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1148/rg.252045176</ArticleId>
            <ArticleId IdType="pubmed">15798063</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murphey MD, Smith WS, Smith SE, Kransdorf MJ, Temple HT. From the archives of the AFIP. Imaging of musculoskeletal neurogenic tumors: radiologic-pathologic correlation. Radiographics. 1999;19:1253–1280. PMid:10489179.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10489179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bredella MA, Torriani M, Hornicek F, et al.  Value of PET in the assessment of patients with neurofibromatosis type I. AJR. 2007;189:928–935. doi: 10.2214/AJR.07.2060. . PMid:17885067.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2214/AJR.07.2060</ArticleId>
            <ArticleId IdType="pubmed">17885067</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wasa J, Nishida Y, Tsukushi S, et al.  MRI features in the differentiation of malignant peripheral nerve sheath tumors and neurofibromas. AJR. 2010;194:1568–1574. doi: 10.2214/AJR.09.2724. . PMid:20489098.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2214/AJR.09.2724</ArticleId>
            <ArticleId IdType="pubmed">20489098</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mautner VF, Friedrich RE, von Deimling A, et al.  Malignant peripheral nerve sheath tumors in neurofibromatosis type 1: MRI supports the diagnosis of malignant plexiform neurofibroma. Neuroradiology. 2003;45:615–625.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12898075</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Van Herendael BH, Heyman SRG, Vanhoenacker FM, et al.  The value of magnetic resonance imaging in the differentiation between malignant peripheral nerve-sheath tumors and non-neurogenic malignant soft-tissue tumors. Skeletal Radiol. 2006;35:745–753. doi: 10.1007/s00256-006-0160-y. . PMid:16775712.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00256-006-0160-y</ArticleId>
            <ArticleId IdType="pubmed">16775712</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bhargava R, Parham DM, Lasater OE, Chari RS, Chen G, Fletcher BD. MR imaging differentiation of benign and malignant peripheral nerve sheath tumors: use of the target sign. Pediatr Radiol. 1997;27:124–129. doi: 10.1007/s002470050082. . PMid:9028843.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s002470050082</ArticleId>
            <ArticleId IdType="pubmed">9028843</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McConnell YJ, Giacomantonio CA. Malignant triton tumors–complete surgical resection and adjuvant radiotherapy associated with improved survival. J Surg Oncol. 2012;106:51–56. doi: 10.1002/jso.23042. . PMid:22253011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jso.23042</ArticleId>
            <ArticleId IdType="pubmed">22253011</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brooks JS, Freeman M, Enterline HT. Malignant “Triton” tumors. Natural history and immunohistochemistry of nine new cases with literature review. Cancer. 1985;55:2543–2549. doi: 10.1002/1097-0142(19850601)55:11&lt;2543::AID-CNCR2820551105&gt;3.0.CO;2-4. . PMid:3922610.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/1097-0142(19850601)55:11&lt;2543::AID-CNCR2820551105&gt;3.0.CO;2-4</ArticleId>
            <ArticleId IdType="pubmed">3922610</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Han DH, Kim DG, Chi JG, Park SH, Jung HW, Kim YG. Malignant triton tumor of the acoustic nerve. Case report. J Neurosurg. 1992;76:874–877. PMid:1564550.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1564550</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Victoria L, McCulloch TM, Callaghan EJ, Bauman NM. Malignant triton tumor of the head and neck: a case report and review of the literature. Head Neck. 1999;21:663–670. doi: 10.1002/(SICI)1097-0347(199910)21:7&lt;663::AID-HED12&gt;3.0.CO;2-4. . PMid:10487955.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/(SICI)1097-0347(199910)21:7&lt;663::AID-HED12&gt;3.0.CO;2-4</ArticleId>
            <ArticleId IdType="pubmed">10487955</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yimaz MR, Bek S, Bekmezci T, Gokduman C, Solak A AS. Malignant triton tumor of the lumbar spine. Spine. 2004;29:E399–E401. PMid:15371720.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15371720</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
